Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Xencor Inc (NASDAQ:XNCR)

23.26
Delayed Data
As of Mar 22
 +0.02 / +0.09%
Today’s Change
10.95
Today|||52-Week Range
29.38
-11.63%
Year-to-Date
Novartis' Acute Heart Failure Drug Fails in Late-Stage Study
Mar 22 / Zacks.com - Paid Partner Content
Novartis Breast Cancer Drug OK'd by FDA as First-line Therapy
Mar 14 / Zacks.com - Paid Partner Content
Novartis (NVS) Announces Positive Data on Heart Failure Drug
Mar 20 / Zacks.com - Paid Partner Content